How enduring is the response to ECP in appropriately selected patients with CTCL? What percentage of CTCL patients who have failed initial therapy can be expected to respond? And what are the characteristics of the dose-response curve?

How enduring is the response to ECP in appropriately selected patients with CTCL? What percentage of CTCL patients who have failed initial therapy can be expected to respond? And what are the characteristics of the dose-response curve?

How enduring is the response to ECP in appropriately selected patients with CTCL? What percentage of CTCL patients who have failed initial therapy can be expected to respond? And what are the characteristics of the dose-response curve?

 

 

 

 


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Richard Edelson, MD

Richard Edelson, MD

Aaron B. and Marguerite Lerner Professor of Dermatology
Chair and Professor
Department of Dermatology
Yale School of Medicine